Case Review Video: Management of Myocarditis Patient

Impella 5.0® Heart Pump Support Until Transplant Dr. Roberta Bogaev and Dr. Shashank Desai present a case study in wh...

AMI Cardiogenic Shock Management with NCSI Algorithm

Case Study Video with Dr. Inder Singh Dr. Inder Singh presents a case study of a patient with AMI cardiogenic shock wh...

Case Review Video: AMI Cardiogenic Shock

Heart Recovery in AMI Cardiogenic Shock Patients Dr. Bryan Kluck and Dr. Gautam Kumar discuss strategies for managing...

Discussion Video: Management of Cardiogenic Shock in CCU

Managing Impella Patients in the CCU Dr. Joseph Parrillo, Dr. Brian Porvin, and Dr. Steven Keller discuss...

Shock Team Protocols with Dr. Truesdell and Dr. Tehrani

Can anyone do it? Absolutely! Alexander Truesdell, MD, FACC, FSCAI, FSVM and Benham Tehrani, MD, interventional cardio...

Impella Management in the CCU with Drs. Parrillo, Porvin, and Keller

Inotrope Weaning, Repositioning, Invasive Monitoring, Impella and ECMO Joseph Parrillo, MD, Brian Porvin, DO, and Stev...

INOVA Heart and Vascular Heart Recovery Initiative

Instituting a Cardiogenic Shock Protocol to Improve Outcomes Alexander Truesdell, MD and Behnam Tehrani, MD, intervent...

Dr. Alexander Truesdell: “Team of Teams” for Treating Cardiogenic Shock

Dr. Alex Truesdell of Virginia Heart discusses how a “team of teams” approach to treating cardiogenic shock can standardize...

Dr. Bill O’Neill: New Data from NCSI & Improving Outcomes in Cardiogenic Shock

“This is a coalition of the willing…I think all of you have to decide tomorrow when you go home, in your hospit...

Best Practices for Access and Closure with the Impella® Device

Dr. Shon Chakrabarti joins Dr. Alex Truesdell who talks to us about best practices for vascular access and closure and details...

Quick Tips on Access and Closure

Dr. Alex Truesdell provides his top 3 tips for safe access and closure with the Impella device which include utilizing all of y...

For Best Outcomes in AMI Cardiogenic Shock, Place Impella 2.5® or Impella CP® Pre-PCI

A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance Database and physician-initiated National Cardio...

Considerations for Impella vs. ECMO

Dr. Michael Tong, Director of Heart Transplantation; Dr. Edward Soltesz, Surgical Director; and Dr. Shinya Unai, Cardiovascular...

Impella RP® Heart Pump Patient Selection Criteria Checklist

Use this FDA-approved checklist to guide treatment decisions and determine if the Impella RP is right for your patients....

Dr. Michael Amponsah Cardiogenic Shock Case with Impella CP

Dr. Michael Amponsah of Central New York Cardiology/Mohawk Valley Health System shares a case of Impella CP for a non-ischemic...

The Door-to-Unloading (DTU) STEMI Safety & Feasibility Trial

Navin Kapur, MD, executive director of the CardioVascular Center for Research and Innovation at Tufts Medical Center, discusses...

Best Practice Protocols for Cardiogenic Shock Showing Improved Outcomes Within the WellStar System

Dr. Salvatore Mannino, Director of the Short-Term Mechanical Circulatory Support Program at WellStar Health System joins Dr. Se...

Dr. O’Neill’s IQ Data and AMICS Presentation from TCT 2018

Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) suppor...

National Cardiogenic Shock Initiative: 1 Year Later

Video Chapters:The Impact of The Cardiogenic Shock Initiative (NCSI):...

Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device

Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) da...

Cardiogenic Shock Due to Severe Multi-Vessel Disease

Dr. Alexander Truesdell, Interventional Cardiologist from Inova Heart & Vascular Institute, presents a case of cardiogenic...

Hybrid Closure Technique with Impella

Rajiv Tayal, MD, Director of Structural Heart Disease at JFK Medical Center, presents information from a clinical paper he co-a...

Step-by-Step Guide to Left Heart Unloading with Impella 5.0®

The Impella 5.0 is approved for use in cardiogenic shock, and is proven to unload the left ventricle and support the systemic c...

Step-by-Step Guide to Left Heart Unloading with Impella LD®

For patients in post cardiotomy cardiogenic shock (PCCS), the Impella LD can assist in the efforts to successfully unload the l...

Step-by-Step Guide to Right Heart Unloading with Impella® RP

The Impella RP is the only FDA approved support device for the treatment of right heart failure....

Left and Right-Side Impella Support in Cardiogenic Shock

Dr. Michael McDaniel of Emory School of Medicine and Dr. Rajesh Sachdeva of Morehouse School of Medicine present a case review...

Optimal Techniques for Gaining Femoral Access

Obtaining Femoral Access: Optimal Techniques Dr. Michael Lim of St. Louis University presents an overvi...

Identification of Complications and Early Management

Dr. Adhir Shroff of the University of Illinois at Chicago recently presented at the SCAI Fellows 2017 conference during a works...

Heart Team Approach to Treating Cardiogenic Shock

Dr. Alexander Truesdell of INOVA Heart and Vascular Institute compares his experience in combat medicine and combat medical car...

Abiomed Cardiogenic Shock Protocol

The Impella 2.5®, Impella CP® and Impella 5.0®/ Impella LD® Heart Pumps and Impella RP® Heart Pump, in conjunction with th...

Cardiogenic Shock Clinical Dossier

Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now  ...